Answers are grounded in this paper and cite their sources.
Background: Gestational and congenital syphilis remain important challenges to maternal and pediatric healthcare in Brazil despite the availability of screening and effective treatment. This study described changes in national indicators from 2015 to 2024 and compared the five Brazilian regions in 2024. Methods: An ecological, descriptive, retrospective study based on aggregated data from the Brazilian Notifiable Diseases Information System and live-birth denominators from the Live Birth Information System, as published in the 2025 Brazilian Syphilis Epidemiological Bulletin. Absolute counts, rates per 1,000 live-births, and relative changes between the first and last years were assessed. Results: The gestational syphilis detection rate increased from 10.9 to 35.4 per 1,000 live-births between 2015 and 2024, a relative increase of 224.8%. Congenital syphilis incidence increased from 6.6 to 9.6 per 1,000 live-births, a 45.5% increase. In 2024, 89,724 gestational and 24,443 congenital syphilis cases were reported. The Southeast had the highest regional gestational syphilis detection rate (43.7) and congenital syphilis incidence (10.1). There were also 183 infant deaths attributed to congenital syphilis, equivalent to 7.2 per 100,000 live births. Conclusions: Gestational syphilis detection increased substantially, whereas congenital syphilis incidence remained high, with regional differences. Aggregated records cannot establish causality or individual vertical transmission risk. These findings highlight the importance of timely diagnosis and treatment and surveillance integrated with prenatal care.
No takes yet. Share an insight, caveat, or question.
Basso et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: